
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
How to Handle Elevated Triglycerides: Life after PROMINENT
Angela Pirillo, Alberico L. Catapano
Current Atherosclerosis Reports (2023) Vol. 25, Iss. 12, pp. 921-929
Closed Access | Times Cited: 8
Angela Pirillo, Alberico L. Catapano
Current Atherosclerosis Reports (2023) Vol. 25, Iss. 12, pp. 921-929
Closed Access | Times Cited: 8
Showing 8 citing articles:
Advancements in risk stratification and management strategies in primary cardiovascular prevention
Fotios Barkas, Yusuf Ziya Şener, Pelin Golforoush, et al.
Atherosclerosis (2024) Vol. 395, pp. 117579-117579
Closed Access | Times Cited: 18
Fotios Barkas, Yusuf Ziya Şener, Pelin Golforoush, et al.
Atherosclerosis (2024) Vol. 395, pp. 117579-117579
Closed Access | Times Cited: 18
Research progress on the mechanism and markers of metabolic disorders in the occurrence and development of cognitive dysfunction after ischemic stroke
Huaqiang Li, Xiaohua Ke, Bainian Feng, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access | Times Cited: 2
Huaqiang Li, Xiaohua Ke, Bainian Feng, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access | Times Cited: 2
ANGPTL3 and ApoC-III inhibitors for treating hypertriglyceridemia in context: horses for courses?
Dick C. Chan, Gerald F. Watts
Current Opinion in Lipidology (2024) Vol. 35, Iss. 3, pp. 101-109
Closed Access | Times Cited: 9
Dick C. Chan, Gerald F. Watts
Current Opinion in Lipidology (2024) Vol. 35, Iss. 3, pp. 101-109
Closed Access | Times Cited: 9
Hypertriglyceridemia Therapy: Past, Present and Future Perspectives
Ileana Canfora, Sabata Pierno
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9727-9727
Open Access | Times Cited: 5
Ileana Canfora, Sabata Pierno
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9727-9727
Open Access | Times Cited: 5
Great debate: Plasma triglycerides are an important causal factor and therapeutic target for atherosclerotic cardiovascular disease
Jan Borén, Chris J. Packard, Børge G. Nordestgaard, et al.
European Heart Journal (2025)
Closed Access
Jan Borén, Chris J. Packard, Børge G. Nordestgaard, et al.
European Heart Journal (2025)
Closed Access
Triglycerides: the past, the present, and the future
Eugene Braunwald
European Heart Journal (2024) Vol. 45, Iss. 37, pp. 3780-3781
Open Access | Times Cited: 3
Eugene Braunwald
European Heart Journal (2024) Vol. 45, Iss. 37, pp. 3780-3781
Open Access | Times Cited: 3
Impact of Remnant Cholesterol on Cardiovascular Risk in Diabetes
Daniel Elías-López, Benjamin Nilsson Wadström, Signe Vedel‐Krogh, et al.
Current Diabetes Reports (2024)
Closed Access | Times Cited: 1
Daniel Elías-López, Benjamin Nilsson Wadström, Signe Vedel‐Krogh, et al.
Current Diabetes Reports (2024)
Closed Access | Times Cited: 1
Phospholipid biomarkers of coronary heart disease
Shin–ya Morita
Journal of Pharmaceutical Health Care and Sciences (2024) Vol. 10, Iss. 1
Open Access
Shin–ya Morita
Journal of Pharmaceutical Health Care and Sciences (2024) Vol. 10, Iss. 1
Open Access